Results 21 to 30 of about 44,802 (314)

Drug-Induced Heart Failure (Part 1: The Urgency of the Problem, the Prevalence, the Effect of Certain Groups of Drugs on the Risk of Development/Progression Heart Failure)

open access: yesБезопасность и риск фармакотерапии, 2020
Despite all the achievements of modern medicine, heart failure remains one of the most prevalent, severe and prognostically unfavorable conditions that requires close attention of the medical community. The diversity of the clinical picture and the large
O. D. Ostroumova, I. V. Goloborodova
doaj   +1 more source

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

open access: yesCochrane Database of Systematic Reviews, 2019
BACKGROUND Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation often recurs after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence.
Lucie Valembois   +5 more
semanticscholar   +1 more source

Homozygous CREM-IbΔC-X Overexpressing Mice Are a Reliable and Effective Disease Model for Atrial Fibrillation

open access: yesFrontiers in Pharmacology, 2018
Background: Atrial fibrillation (AF) is a significant cause of morbidity and mortality with foreseeably increasing prevalence. While large animal models of the disease are well established but resource intensive, transgenic AF mouse models are not yet ...
Frank T. Stümpel   +6 more
doaj   +1 more source

Testing of newly synthesized propafenone derivatives antiarrhythmic activity in aconitic model of cardiac arrhythmia in rats [PDF]

open access: yesVeterinarski Glasnik, 2014
By applying of aconitic test in in vivo experiments in rats under deep anesthesia, there was investigated the antiarrhythmic potential of newly synthetized fluorinated derivatives of propafenone.
Ivković Branka   +6 more
doaj   +1 more source

Effects of antiarrhythmics on the electrical restitution in perfused guinea‐pig heart are critically determined by the applied cardiac pacing protocol

open access: yesExperimental Physiology, 2019
What is the central question of this study? Are modifications in the restitution of ventricular action potential duration induced by antiarrhythmic drugs the same when assessed with premature extrastimulus application at variable coupling intervals (the ...
O. Osadchii
semanticscholar   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Class III Antiarrhythmics and Periprocedural Torsades de Pointes

open access: yesJACC: Case Reports, 2023
This case series describes 2 women on prolonged therapy with class III antiarrhythmics who developed torsades de pointes polymorphic ventricular tachycardia in the setting of catheter ablation for atrial fibrillation as a result of QTc prolonging factors.
Cristina M. Font, MD   +1 more
doaj   +1 more source

Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator [PDF]

open access: yes, 2003
Several studies have reported improved survival rates thanks to the use of an implantable cardioverter defibrillator (ICD) in the treatment of patients with life-threatening arrhythmia.
Coster, Jenifer   +11 more
core   +1 more source

The association between cardiac drug therapy and anxiety among cardiac patients: results from the national DenHeart survey

open access: yesBMC Cardiovascular Disorders, 2022
Background Neuropsychiatric side effects of cardiac drugs such as nervousness, mood swings and agitation may be misinterpreted as symptoms of anxiety.
Camilla Rotvig   +10 more
doaj   +1 more source

Drugs acting on the heart: antiarrhythmics

open access: yes, 2018
Arrhythmias are abnormalities of cardiac rate or rhythm occurring for a variety of reasons. They are common in the perioperative period and in intensive care. Causes may reflect an underlying heritable predisposition, the presence of new pathology either
C Hebbes (7739255)   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy